ResMed Inc/ US7611521078 /
1/24/2025 9:59:57 PM | Chg. +1.68 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
250.55USD | +0.67% | 30,386 Turnover: 7.58 mill. |
-Bid Size: - | -Ask Size: - | 36.77 bill.USD | 0.77% | 36.10 |
GlobeNewswire
8/28/2024
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswire
8/15/2024
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader ...
GlobeNewswire
7/25/2024
NATIONAL CENTER ON SHAKEN BABY SYNDROME AND XEALTH INCREASE SPEED AND ACCESSIBILITY OF CRITICAL PARE...
GlobeNewswire
6/27/2024
XEALTH LAUNCHES DEWEY, THE INDUSTRY’S FIRST PERFORMANCE-BASED, DIGITAL HEALTH BENCHMARKING TOOL
GlobeNewswire
6/10/2024
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
5/23/2024
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
5/16/2024
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
5/16/2024
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
5/7/2024
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
4/10/2024
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH